Aprea Therapeutics Inc.
Organization details
- Legal name
- Aprea Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Doylestown
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- APRE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001781983
Board of directors
-
Bernd R. Seizinger · DirectorSince 2023
-
Gabriela Gruia · DirectorSince 2023
-
Jean-Pierre Bizzari · DirectorSince 2023
-
John B. Henneman III · DirectorSince 2023
-
Marc Duey · DirectorSince 2023
-
Michael Grissinger · DirectorSince 2023
-
Oren Gilad · Director · President/CEOSince 2023
-
Richard Peters · DirectorSince 2023
-
Rifat Pamukcu · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
93.4%
-
98.9%
-
99.0%
Board connections
5 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
ADC Therapeutics SA Same sectorvia Jean-Pierre Bizzari
-
Adicet Bio Inc. Same sectorvia Michael Grissinger
-
Akari Therapeutics plc Same sectorvia Michael Grissinger
-
Anika Therapeutics Inc. Same sectorvia John B. Henneman III
-
Halozyme Therapeutics Inc. Same sectorvia Jean-Pierre Bizzari
-
Lipocine Inc. Same sectorvia Michael Grissinger
-
Oncolytics Biotech Inc. Same sectorvia Bernd R. Seizinger
-
Orthofix Medical Inc. Same sectorvia John B. Henneman III
-
TScan Therapeutics Inc. Same sectorvia Gabriela Gruia
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $61,039
- 4 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Michael Grissinger Director | Grant or award | +3,135 | — | — |
| Jun 16, 2026 | Gabriela Gruia Director | Grant or award | +3,135 | — | — |
| Jun 16, 2026 | Richard Peters Director | Grant or award | +3,135 | — | — |
| Jun 16, 2026 | John B. Henneman III Director | Grant or award | +3,135 | — | — |
| Jun 16, 2026 | Jean-Pierre Bizzari Director | Grant or award | +3,135 | — | — |
| Jun 16, 2026 | Marc Duey Director | Grant or award | +3,135 | — | — |
| Jun 16, 2026 | Rifat Pamukcu Director | Grant or award | +3,135 | — | — |
| Jun 16, 2026 | Bernd R. Seizinger Director | Grant or award | +3,135 | — | — |
| Mar 12, 2026 | Oren Gilad Director, Officer (President/CEO) | Grant or award | +20,175 | — | — |
| Mar 12, 2026 | Hamill John P. Officer (SrVP/CFO/Prin Fin & Acct Ofcr) | Grant or award | +10,095 | — | — |
| Jan 30, 2026 | Oren Gilad Director, Officer (President/CEO) | Open-market purchase | +28,100 | $0.89 | $25,009 |
| Jan 30, 2026 | Hamill John P. Officer (SrVP/CFO/Prin Fin & Acct Ofcr) | Open-market purchase | +5,700 | $0.89 | $5,073 |
| Dec 10, 2025 | Marc Duey Director | Open-market purchase | +21,459 | $1.17 | $25,107 |
| Dec 10, 2025 | Hamill John P. Officer (SrVP/CFO/Prin Fin & Acct Ofcr) | Open-market purchase | +5,000 | $1.17 | $5,850 |
| Jun 5, 2025 | Bernd R. Seizinger Director | Grant or award | +1,045 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Aprea Therapeutics Inc.
Who is the CEO of Aprea Therapeutics Inc.?
Oren Gilad is Aprea Therapeutics Inc.'s President, CEO.
How many directors are on Aprea Therapeutics Inc.'s board?
Aprea Therapeutics Inc.'s board has 9 directors: Bernd R. Seizinger, Gabriela Gruia, Jean-Pierre Bizzari, John B. Henneman III, Marc Duey, Michael Grissinger, Oren Gilad, Richard Peters and Rifat Pamukcu.
Are Aprea Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Aprea Therapeutics Inc. insiders bought $61,039 of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="aprea-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.